Latest Chemoembolization Stories
Study presented at SIR: Surefire results in statistically significant tumor uptake ATLANTA, March 3, 2015 /PRNewswire/ --
In a series of studies involving 140 American men and women with liver tumors, researchers at Johns Hopkins have used specialized 3-D MRI scans to precisely measure living and dying tumor tissue to quickly show whether highly toxic chemotherapy – delivered directly through a tumor's blood supply – is working.
WESTMINSTER, Colo., March 13, 2014 /PRNewswire/ -- Surefire Medical, Inc., developer of a new class of infusion systems
INTIO's TipTRAC™ will be demonstrated at the World Congress of Interventional Oncology.
Surefire Medical's first-in-class antireflux infusion system can accommodate smaller vessels and selective procedures in direct-to-tumor cancer treatment, and significantly increases penetration
- Emitting flashes of light; glittering.